AI Science Tracker

Department of Bioscience and Bioinformatics, Kyushu Institute of Technology, 680-4 Kawazu, Iizuka, Fukuoka 820-8502, Japan.

1 discovery from 2024

Discoveries

De novo generation of dual-target compounds using artificial intelligence

Source check: Needs source check. Not independent scientific confirmation.

Finding: De novo generation of dual-target compounds using artificial intelligence. Generative methods designed compounds predicted to bind both ADORA2A and PDE4D. 10 compounds were synthesized and profiled in binding assays against 39 human proteins; 3 interacted with both targets with high specificity. Evidence limits: Functional activity in cells or animals was not reported in the abstract; potency not assessed. Reviewed from Europe PMC abstract only.

Technology: Genetic-algorithm fragment assembly and GAN-based reinforcement learning generators

Publication: Peer-reviewed paper · Test context: direct test. Catalog categories, not an evidence grade.

AI contribution
Generative methods designed compounds predicted to bind both ADORA2A and PDE4D.
Test and result
10 compounds were synthesized and profiled in binding assays against 39 human proteins; 3 interacted with both targets with high specificity.
Limitation / still unknown
Functional activity in cells or animals was not reported in the abstract; potency not assessed.
Evidence sources and annotation context

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

Evidence sources: https://europepmc.org/article/MED/39801837

Needs source check · editorial details

The source has not been fully checked or contains conflicting information. Independent confirmation is not assessed by this label.

Source type: paper. Paper: not linked in this catalog; this does not mean no paper exists.

Review scope and date are not recorded; source checked does not establish full-text review.

No follow-up recorded; this is not a claim that no follow-up exists. Follow-up review scope and date are not recorded. No source-supported relationships recorded.

Editorial assessment: Impact 3/5 · Validation 3/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Open the interactive profile for the timeline, or browse all organizations and model families.